BIOMAT Database Logo BIOMAT Database Logo

[Effect of thymus cytomedins (thymalin) on the course of skin diseases]. 1987

O K Shaposhnikov, and V F Gorbunov, and V I Shchedrin, and T N Karachunova, and V M Vorob'ev

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000917 Antibody Formation The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS. Antibody Production,Antibody Response,Antibody Responses,Formation, Antibody,Production, Antibody,Response, Antibody,Responses, Antibody
D012871 Skin Diseases Diseases involving the DERMIS or EPIDERMIS. Dermatoses,Skin and Subcutaneous Tissue Disorders,Dermatosis,Skin Disease

Related Publications

O K Shaposhnikov, and V F Gorbunov, and V I Shchedrin, and T N Karachunova, and V M Vorob'ev
[Effect of thymalin on the thymus and immunologic indices of irradiated animals].
January 1984, Radiobiologiia,
O K Shaposhnikov, and V F Gorbunov, and V I Shchedrin, and T N Karachunova, and V M Vorob'ev
[Effect of thymalin on the course of suppurative peritonitis in children].
March 1987, Vestnik khirurgii imeni I. I. Grekova,
O K Shaposhnikov, and V F Gorbunov, and V I Shchedrin, and T N Karachunova, and V M Vorob'ev
Effect of Thymalin on the Tumor and Thymus under Conditions of Activation Therapy In Vivo.
May 2018, Bulletin of experimental biology and medicine,
O K Shaposhnikov, and V F Gorbunov, and V I Shchedrin, and T N Karachunova, and V M Vorob'ev
[Effect of a thymus preparation (thymalin) on burn healing and the immunologic reactivity of the body].
October 1984, Khirurgiia,
O K Shaposhnikov, and V F Gorbunov, and V I Shchedrin, and T N Karachunova, and V M Vorob'ev
[Comparative study of the effect of the thymus preparations thymoptin and thymalin on fibrin-monomer polymerization].
January 1989, Farmakologiia i toksikologiia,
O K Shaposhnikov, and V F Gorbunov, and V I Shchedrin, and T N Karachunova, and V M Vorob'ev
[The effect of thymalin on lipid metabolism and the clinical course of ischemic heart disease].
September 1992, Likars'ka sprava,
O K Shaposhnikov, and V F Gorbunov, and V I Shchedrin, and T N Karachunova, and V M Vorob'ev
[The effect of thymalin, dalargin and "Mucosalin" on the course of an experimental duodenal ulcer].
January 1995, Likars'ka sprava,
O K Shaposhnikov, and V F Gorbunov, and V I Shchedrin, and T N Karachunova, and V M Vorob'ev
[Effect of influenza & common infection on the etiology & course of skin diseases].
May 1958, Die Medizinische,
O K Shaposhnikov, and V F Gorbunov, and V I Shchedrin, and T N Karachunova, and V M Vorob'ev
Experimental and clinical study of the thymus polypeptide factor thymalin.
January 1984, Human physiology,
O K Shaposhnikov, and V F Gorbunov, and V I Shchedrin, and T N Karachunova, and V M Vorob'ev
[Effect of thymalin on immunologic reactivity of patients with non-specific lung diseases].
January 1989, Terapevticheskii arkhiv,
Copied contents to your clipboard!